Category Ranking

98%

Total Visits

921

Avg Visit Duration

2 minutes

Citations

20

Article Abstract

The productivity of ecosystems and their capacity to support life depends on access to reactive nitrogen (N). Over the past century, humans have more than doubled the global supply of reactive N through industrial and agricultural activities. However, long-term records demonstrate that N availability is declining in many regions of the world. Reactive N inputs are not evenly distributed, and global changes-including elevated atmospheric carbon dioxide (CO) levels and rising temperatures-are affecting ecosystem N supply relative to demand. Declining N availability is constraining primary productivity, contributing to lower leaf N concentrations, and reducing the quality of herbivore diets in many ecosystems. We outline the current state of knowledge about declining N availability and propose actions aimed at characterizing and responding to this emerging challenge.

Download full-text PDF

Source
http://dx.doi.org/10.1126/science.abh3767DOI Listing

Publication Analysis

Top Keywords

declining availability
8
evidence consequences
4
declining
4
consequences declining
4
declining nitrogen
4
availability
4
nitrogen availability
4
availability terrestrial
4
terrestrial ecosystems
4
ecosystems productivity
4

Similar Publications

Heart failure (HF) is a multifactorial and pathophysiological complex syndrome, involving not only neurohormonal activation but also oxidative stress, chronic low-grade inflammation, and metabolic derangements. Central to the cellular defence against oxidative damage is nuclear factor erythroid 2-related factor 2 (Nrf2), a transcription factor that orchestrates antioxidant and cytoprotective responses. Preclinical in vitro and in vivo studies reveal that Nrf2 signalling is consistently impaired in HF, contributing to the progression of myocardial dysfunction.

View Article and Find Full Text PDF

Advances in Gene Therapy Clinical Trials for Hemophilia Care.

Curr Gene Ther

September 2025

Centre for Research Impact & Outcome-Chitkara College of Pharmacy, Chitkara University, Rajpura, Punjab 140401, India.

Gene therapy has revolutionized the therapeutic landscape for hemophilia A and B, offering the prospect for persistent endogenous production of coagulation factors VIII and IX. Recent advances in adeno-associated virus (AAV)-mediated gene transfer, particularly the approvals of valoctocogene roxaparvovec (Roctavian) and etranacogene dezaparvovec (Hemgenix), mark significant milestones in hemophilia care. This mini-review synthesizes emerging clinical data from phase I-III trials published between 2022 and 2025, emphasizing efficacy, durability, and immunogenicity profiles of leading AAV-based therapies.

View Article and Find Full Text PDF

Background: Cardiac positron emission tomography (PET) and single-photon emission computed tomography (SPECT) are widely used for the assessment of coronary artery disease. While SPECT remains more available, workforce shortages and training demands contribute to geographic disparities in PET availability, impacting patient access to advanced imaging. Therefore, we assessed trends in the U.

View Article and Find Full Text PDF

An iron-hard legacy? An analysis of metal accumulation and recovery over time in Brazil's Atlantic Rainforest plants after the Fundão Dam collapse.

J Hazard Mater

September 2025

Laboratório de Estudos Aplicados em Fisiologia Vegetal, Instituto Federal Goiano, Campus Rio Verde Rio Verde, GO 75.901-970, Brazil.

The study investigates the long-term effects of the 2015 Fundão tailings dam collapse in Brazil, focusing on metal accumulation in soil, plants and its implications for ecosystem recovery. The research, conducted between 2021 and 2024, analyzed 3311 individuals from areas directly and indirectly affected by the dam collapse, as well as from non-affected areas, integrating geochemical, spatial, and temporal analyses. Metal concentration and cellular damage were evaluated in roots and leaves.

View Article and Find Full Text PDF

Alzheimer's disease (AD) represents a growing global health burden, underscoring the urgent need for reliable diagnostic and prognostic biomarkers. Although several disease-modifying treatments have recently become available, their effects remain limited, as they primarily delay rather than halt disease progression. Thus, the early and accurate identification of individuals at elevated risk for conversion to AD dementia is crucial to maximize the effectiveness of these therapies and to facilitate timely intervention strategies.

View Article and Find Full Text PDF